Livanova said Monday a trial of its obstructive sleep apnea (OSA) implant met its primary ... If approved, aura6000 will compete with Inspire’s OSA implant and, potentially, Nyxoah’s near-approval ...

A newer option is a surgically implanted device called Inspire (inspiresleep.com ... symptom severity by almost two-thirds in ...

Additionally, there is a functional alteration during the various stages of sleep. In nonrapid eye ... with patients who do not have an implanted device. Our main goal was to evaluate the impact ...

As Veterans Day approaches, those who served our nation face a quiet healthcare crisis. The Department of Veterans Affairs ...

An unhealthy diet and an indolent life are well known causes of heart disease and stroke. But sleep apnea—where people ...

LivaNova today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints.

Implantable cardiac pacing devices may have a role in both the diagnosis and therapy of sleep apnea, which may be of particular importance given the seemingly wide coprevalence of cardiac ...

Sleep Apnea Contributes to Dementia in Older Adults ... In addition, this association was partly attributed to poor sleep, ... Keep Devices out of Bed for Better Sleep Sep. 3, 2024 — Despite ...

Methods: Data from the Medtronic Product Surveillance Registry for all patients in the US who underwent a cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) ...